Abpro Holdings Inc Ordinary Shares ABPO
Trading Information
- Previous Close Price
- $0.40
- Day Range
- $0.36–0.42
- 52-Week Range
- $0.09–7.34
- Bid/Ask
- $0.25 / $0.45
- Shares Outstanding
- 5.90M
- Market Cap
- $2.36M
- Volume/Avg
- 2,384 / 12,996
Key Statistics
- Price/Earnings (Normalized)
- 0.18
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. The company is focused on novel antibody constructs for immuno-oncology, ophthalmology, and infectious diseases. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, the company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- https://www.abpro.co
Valuation
|
Metric
|
ABPO
|
|---|---|
Price/Earnings (Normalized) | 0.18 |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ABPO
Financial Strength
|
Metric
|
ABPO
|
|---|---|
Quick Ratio | 0.52 |
Current Ratio | 0.62 |
Interest Coverage | 2.42 |
Quick Ratio
ABPO
Profitability
|
Metric
|
ABPO
|
|---|---|
Return on Assets (Normalized) | −20.86% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ABPO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|kd>dqx% | LOCK|!sf? | $129B | |||
| Moderna Inc
MRNA
| LOCK|@b%!pb | LOCK|Zx | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Kgc#^?Q | LOCK|P%?> | $77B | |||
| argenx SE ADR
ARGX
| LOCK|S%CG?Tj | LOCK|!Cm | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|tz?&>%$ | LOCK|>& | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<tddV%& | LOCK|!^<f | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|l!!#$#&f | LOCK|ZHyB | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|YYvr<kF | LOCK|F>D | $24B | |||
| Incyte Corp
INCY
| LOCK|F#zStD | LOCK|@L< | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|D#>qjW | LOCK|^# | $14B |
United States